alexa Monoclonal antibody successes in the clinic.
Immunology

Immunology

Immunotherapy: Open Access

Author(s): Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC, Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC, Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC, Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC

Abstract Share this page

Abstract Most monoclonal antibodies in clinical trials are owned by small biotech companies. But with blockbuster-sized revenues and approval rates higher than those for small-molecule drugs, that all may be set to change. This article was published in Nat Biotechnol and referenced in Immunotherapy: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords